[The Effects of 1Alpha,25-Dihydroxyvitamin D3 in Regulation Matrix Metalloproteinase and Tissue Metalloproteinase Inhibitors in Human Osteoblasts].

Li-juan Guo,Xiang-hang Luo,Hui Xie,Hou-de Zhou,Er-yuan Liao
DOI: https://doi.org/10.3760/j.issn:0578-1426.2005.02.014
2005-01-01
Abstract:OBJECTIVE:To characterize the effects of 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] on the expression of matrix metalloproteinase (MMP)-1, MMP-2, membrane-type MMP-1 (MT1-MMP), tissue inhibitors of metalloproteinase-1 (TIMP-1) in human osteoblast, and understand the mechanism by which 1alpha,25(OH)2D3 exert on bone.METHODS:Osteoblasts were interfered by 1alpha,25(OH2D3. Western blot were used to show the action of 1alpha,25(OH)2D3 on the expression of MT1-MMP protein in human osteoblasts. ELISA was done to examine the effect of 1alpha,25(OH)2D3 on the activity of MMP-2. Northern blot analysis was performed to detect vitamin D receptor mRNA levels and to evaluate the effect of 1alpha,25(OH)2D3 on MT1-MMP mRNA levels.RESULTS:The results showed that 1alpha,25(OH)2D3 had no effect on the expression of MMP-1, MMP-2 and TIMP-1 in human osteoblasts; 10(-10) - 10(-8) mol/L 1alpha,25(OH)2D3 induced MT1-MMP expression in a dose-dependent manner (P < 0.05), 10(-10) - 10(-8) mol/L 1alpha,25(OH)2D3 induced the activation of proMMP-2 in a dose-dependent manner in human osteoblasts[The activity of MMP-2 was (42.3 +/- 8.6), (64.4 +/- 11.4), (93.5 +/- 9.9) microg/L respectively, P < 0.05].CONCLUSION:1alpha,25(OH)2D3 may stimulate bone resorption by inducing MT1-MMP production in osteoblasts.
What problem does this paper attempt to address?